Compare Vir Biotechnology Inc. Common Stock (VIR) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs State Street SPDR S&P Homebuilders ETF — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.38 (market cap $1.76B), while State Street SPDR S&P Homebuilders ETF trades at $92.84 (market cap $1.53B). The key difference: Vir Biotechnology Inc. Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and State Street SPDR S&P Homebuilders ETF for 35 Days on average.
| VIR | XHB | |
|---|---|---|
Market Cap | $1.76B | $1.53B |
Volume | 2,764,948 | 1,987,449 |
Sector | Health | Broad Market / Factor |
52-Week High | $11.78 | $121.36 |
52-Week Low | $5.12 | $92.84 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $1.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XHB (SPDR S&P Homebuilders ETF) trades at $94.70, up 0.69% on the day, but faces strong technical headwinds with a bearish moving average signal and key resistance at $95. The ETF reflects the homebuilding sector's sensitivity to mortgage rates, which recently hit 7%, pressuring valuations despite some positive housing data. Recent institutional activity shows mixed sentiment, with Greenland Capital adding a $17.33 million position while CoreCap Advisors reduced its stake by 99.3% in Q2 2026.
The outlook remains cautious amid high mortgage rates and mixed housing data, though potential catalysts include new housing legislation and undervalued sector signals. Risks include rate sensitivity and economic volatility, but long-term exposure to housing demand offers rebound potential. Wall Street sentiment is neutral with focus on affordability trends and policy impacts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
